Bioequivalency Branding Containment FDA Approval 
The Pharma Data
DECEMBER 28, 2020
Amphastar’s newly approved synthetic peptide product was determined by the FDA to be bioequivalent and therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar, which has a recombinant DNA (rDNA)-origin. However, not all forward-looking statements contain these words.
Delveinsight
FEBRUARY 5, 2021
Fortunately, there exists FDA-approved therapies and drugs that double the success rates of quitting. Some of these approved products contain nicotine as an active ingredient, while others do not. Whenever the branded drugs go off-the-market, it paves the way for the entry of generics in the market.
Expert insights. Personalized for you.
52 
Let's personalize your content